Skip to main content

Table 3 Haemodynamic, oxygen and temperature variables

From: Effects of lornoxicam on the physiology of severe sepsis

Parameter

Baseline

Hours after the start of infusion

  

24

48

72

Heart rate (beats/min)

    

Lornoxicam

98 ± 24

99 ± 24

99 ± 22

96 ± 22

Placebo

95 ± 17

100 ± 23

98 ± 23

97 ± 22

Mean arterial pressure (mmHg)

    

Lornoxicam

91 ± 16

92 ± 13

89 ± 13

93 ± 13

Placebo

91 ± 18

93 ± 14

91 ± 12

89 ± 11

Arterial pH

    

Lornoxicam

7.34 ± 0.08

7.36 ± 0.07

7.33 ± 0.10

7.36 ± 0.06

Placebo

7.35 ± 0.07

7.37 ± 0.07

7.34 ± 0.07

7.37 ± 0.05

PaCO2 (torr)

    

Lornoxicam

34.8 ± 12.1

34.6 ± 11.8

35.00 ± 9.2

36.54 ± 11.1

Placebo

32.6 ± 10

33.5 ± 10.2

36.3 ± 10.13

34.33 ± 12

PaO2/FiO2 ratio (torr)

    

Lornoxicam

182 ± 68

186 ± 56

188 ± 64

189 ± 76

Placebo

184 ± 76

187 ± 45

181 ± 68

185 ± 68

SaO2 (%)

    

Lornoxicam

96.1 ± 3

96.1 ± 3.1

95.9 ± 3.8

95.9 ± 4.2

Placebo

96.9 ± 3.1

96.0 ± 3.2

96.0 ± 2.8

95.8 ± 3.9

Temperature (°C)

    

Lornoxicam

37.8 ± 0.75

37.2 ± 0.6

37.8 ± 0.5

37.9 ± 0.4

Placebo

37.6 ± 0.57

37.8 ± 0.4

37.6 ± 0.6

37.8 ± 0.5

  1. No significant differences were found between groups. Data are expressed as mean ± standard deviation. FiO2, fractional oxygen tension; PaCO2, arterial carbon dioxide tension; PaO2, arterial oxygen tension; SaO2, arterial oxygen saturation.